Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
OSTEOPOROSIS AND DIABETES - IN WHICH WAY ARE THEY RELATED?
Osnat Tell-Lebanon
,
Pnina Rotman-Pikielny
Clalit Health Services
Meir Hospital Sapir Medical Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'OSTEOPOROSIS AND DIABETES - IN WHICH WAY ARE THEY RELATED?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Patients with Diabetes
100%
Osteoporosis
100%
Diabetes
100%
Which-way
100%
Type 1 Diabetes Mellitus (T1DM)
66%
Osteoporotic Fractures
66%
Fracture Risk
66%
Pathophysiology
33%
Drug Treatment
33%
Control Subjects
33%
Common Disease
33%
Diagnostic Tool
33%
High Risk
33%
Bone Mineral Density
33%
Decreased Bone Density
33%
Risk Factors
33%
Architectural Structure
33%
Drug Use
33%
Adaptive Mechanism
33%
Type 2 Diabetes Mellitus (T2DM)
33%
Disease Complications
33%
Diabetic Patients
33%
Without Diabetes
33%
Fracture Risk Assessment
33%
FRAX®
33%
Clinical Algorithm
33%
Actual Risk
33%
Structure-property Relationships
33%
Insulin Dose
33%
Bone Strength
33%
Aging Population
33%
Repair Method
33%
Existing Drugs
33%
Bone Disease
33%
Advanced Glycation End Products
33%
Fracture Rate
33%
Bone Turnover
33%
Collagen Structure
33%
Skeletal Phenotype
33%
Long Disease Duration
33%
Thiazolidinediones
33%
Mineral Properties
33%
Product Change
33%
FRAX Tool
33%
Medicine and Dentistry
Diabetes
100%
Patient with Diabetes
100%
Osteoporosis
100%
Bone Density
66%
FRAX
66%
Fragility Fracture
66%
Diseases
66%
Disease Duration
33%
Pathophysiology
33%
Diabetes Mellitus
33%
Prevalence
33%
Maturity Onset Diabetes of the Young
33%
Drug Therapy
33%
Insulin Dependent Diabetes Mellitus
33%
Patient with Type 1 Diabetes
33%
Bone Turnover
33%
Bone Strength
33%
Dual-Energy X-Ray Absorptiometry
33%
Thiazolidinedione
33%
Advanced Glycation End-Product
33%
Bone Disease
33%
Pharmacology, Toxicology and Pharmaceutical Science
Fragility Fracture
100%
Diseases
100%
Prevalence
50%
Diabetes Mellitus
50%
Pharmacotherapy
50%
Pathophysiology
50%
Disease Duration
50%
Insulin Dependent Diabetes Mellitus
50%
Thiazolidinedione
50%
Advanced Glycation End Product
50%
Non Insulin Dependent Diabetes Mellitus
50%
Bone Disease
50%
Biochemistry, Genetics and Molecular Biology
Bone Density
100%
Orthopedic Software
100%
Prevalence
50%
Bone Turnover
50%
Bone Strength
50%
Thiazolidinedione
50%
Advanced Glycation End-Product
50%
Drug Therapy
50%